This previous work led us to propose that TG2 may play an important role in CRC development and progression in early stages of disease, but that there may be a selective advantage for CRC cells to down-regulate TG2 in later-stage disease to facilitate invasion and metastasis. This evidence concerns the gene TGM2 and colorectal carcinoma.